SynSense (formerly aiCTX), the Switzerland-based neuromorphic chip startup, has recently announced the close of a Series A funding round. Led by CTC Capital, the latest round included co-investment from Merck, CAS-Star, Ecovacs, Yunding, and Archer Investment.
The proceeds will be used to fuel R&D and business development, accelerating the commercialization of SynSense’s neuromorphic computing technology.
SynSense is a world-leading high-tech company focused on the design and development of neuromorphic computing and brain-like edge computing processors and smart sensors. Based on more than 20 years of global leading research results and world-leading scientific research strengths of the University of Zurich and the Federal Institute of Technology of Zurich, SynSense was founded in February 2017 to provide groundbreaking sub-milliwatt ultra-low power consumption for a series of AI edge computing application scenarios, as well as ultra-low latency chip design and solution.
The ultra-low-power neuromorphic intelligent processors and sensors designed and developed by the company can realize microwatt-level AI operations and are widely used in IoT real-time signal processing and AI edge computing applications.
Dr. Ning Qiao, CEO of SynSense, is confident in the prospects of SynSense’s next generation smart vision sensors in Smart Home and edge computing markets. “The next years will bring the golden age of neuromorphic computing. Our technology has resonated well with applications in Smart Homes, Robotics and Smart Surveillance. This fundraising round will help us sharpen our technology and achieve industrial penetration. We will grasp this unique chance to launch our products and seize the market.”